Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of lacosamide in children with epilepsy under 16 years of age
ChiCTR2100046564Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lacosamide in epilepsy (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoint: Seizure frequency. Planned start May 2021; status: not yet recruiting.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2100046564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046564.